ETHOS - Ethos Equities CH indexed, Corporate Governance Z

Reference Data

ISIN CH1109038336
Valor Number 110903833
Bloomberg Global ID
Fund Name ETHOS - Ethos Equities CH indexed, Corporate Governance Z
Fund Provider Ethos Genève, Switzerland
Phone: +41 22 716 15 55
E-Mail: info@ethosfund.ch
Web: www.ethosfund.ch
Fund Provider Ethos
Representative in Switzerland
Distributor(s) Credit Suisse AG
Zürich
Phone: +41 44 333 11 11 UBS AG
Zürich
Phone: +41 44 234 11 11 Vontobel Fonds Services AG
Zürich
Phone: +41 58 283 74 77
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets)
Redemption Condition The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets)
Investment Strategy *** The sub-fund's objective is to achieve long-term capital gains by outperforming its benchmark index, the Bloomberg Barclays Global Aggregate Ex CHF Total Return Index Hedged CHF, over a time horizon corresponding to one full economic cycle. The sub-fund is actively managed by combining market research with issuer analysis, as well as taking into consideration environmental, social, and governance (ESG) criteria, with the aim of building a portfolio of securities corresponding to its objective while offering the best risk-adjusted returns. The sub-fund invests mainly in bonds issued in Swiss francs or in any other foreign currency, by private or public issuers from all over the world outside Switzerland, having a minimum Investment Grade rating.
Peculiarities

Fund Prices

Current Price * 322.78 CHF 08.08.2025
Previous Price * 323.09 CHF 07.08.2025
52 Week High * 333.84 CHF 03.03.2025
52 Week Low * 281.75 CHF 09.04.2025
NAV * 322.78 CHF 08.08.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 126,295,044
Unit/Share Assets *** 22,333,175
Trading Information SIX

Performance

YTD Performance +7.43% 31.12.2024
08.08.2025
1 month +0.46% 08.07.2025
08.08.2025
3 months +1.03% 08.05.2025
08.08.2025
6 months -0.24% 10.02.2025
08.08.2025
1 year +6.56% 08.08.2024
08.08.2025
2 years +15.85% 08.08.2023
08.08.2025
3 years +17.30% 08.08.2022
08.08.2025
5 years +6.06% 31.08.2021
08.08.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Nestle SA 14.57%
Roche Holding AG 8.99%
Novartis AG Registered Shares 8.79%
Zurich Insurance Group AG 7.08%
UBS Group AG 6.57%
ABB Ltd 5.73%
Compagnie Financiere Richemont SA Class A 3.71%
Swiss Re AG 3.61%
Lonza Group Ltd 3.53%
Sika AG 2.74%
Last data update 30.04.2025

Cost / Risk

TER 0.06%
TER date 31.12.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.25%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.07.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)